Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Werewolf Therapeutics, Inc.HOWL · Entity 7244 | Chief Medical Officer | January 02, 2025 | January 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Werewolf Therapeutics, Inc.
Report date January 02, 2025 · Filed January 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.56 · Expires 2034-12-31 | Direct | 187,500 |
Reported balance
After 2025-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-01-02 · Grant · Acquired 187,500 · Balance 187,500 F1: The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in equal monthly installments over four years, with the initial vesting to commence on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.56 · Expires 2034-12-31 | Direct | 68,151 |
Reported balance
After 2025-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-01-02 · Grant · Acquired 68,151 · Balance 68,151 |
Filing footnotes · ownership attribution and instrument terms
F1: The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in equal monthly installments over four years, with the initial vesting to commence on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2025 Filed Jan 6, 2025 22:44 UTC | Werewolf Therapeutics, Inc. HOWL · Entity 7244 | GrantStock Option (right to buy) · Derivative | 68,151 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0000950170-25-002343 · ownership.xml · derivative · entry 2 Isaacs Randi · CIK 0001857797 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,151 Underlying: Common Stock · 68,151 shares Expires 2034-12-31 Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:44 UTC | Werewolf Therapeutics, Inc. HOWL · Entity 7244 | GrantStock Option (right to buy) · Derivative | 187,500 | $0.00 Strike: $1.56 | $0.00 |
DisclosureSEC source: 0000950170-25-002343 · ownership.xml · derivative · entry 1 Isaacs Randi · CIK 0001857797 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 187,500 shares Expires 2034-12-31 F1 · derivative.exercise_date: The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in equal monthly installments over four years, with the initial vesting to commence on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:33 UTC | Werewolf Therapeutics, Inc. HOWL · Entity 7244 | GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0000950170-24-001932 · ownership.xml · derivative · entry 1 Isaacs Randi · CIK 0001857797 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-12-31 F1 · derivative.exercise_date: The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028. Read SEC document |
| January 03, 2023 Filed Jan 10, 2023 02:32 UTC | Werewolf Therapeutics, Inc. HOWL · Entity 7244 | GrantStock Option (right to buy) · Derivative | 103,300 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0000899243-23-001400 · doc4.xml · derivative · entry 1 Isaacs Randi · CIK 0001857797 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,300 Underlying: Common Stock · 103,300 shares Expires 2032-12-31 F1 · derivative.exercise_date: The option was granted on January 3, 2023 with a Vesting Commencement Date of January 1, 2023. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2027. Read SEC document |
| January 06, 2022 Filed Jan 18, 2022 23:34 UTC | Werewolf Therapeutics, Inc. HOWL · Entity 7244 | GrantStock Option (right to buy) · Derivative | 79,516 | $0.00 Strike: $11.55 | $0.00 |
DisclosureSEC source: 0000899243-22-002207 · doc4.xml · derivative · entry 1 Isaacs Randi · CIK 0001857797 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,516 Underlying: Common Stock · 79,516 shares Expires 2032-01-05 F1 · derivative.exercise_date: The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026. Read SEC document |
| April 30, 2021 Filed May 4, 2021 20:30 UTC | Werewolf Therapeutics, Inc. HOWL · Entity 7244 | GrantStock Option (right to buy) · Derivative | 56,786 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018114 · doc4.xml · derivative · entry 3 Isaacs Randi · CIK 0001857797 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,786 Underlying: Common Stock · 56,786 shares Expires 2031-04-29 F3 · derivative.exercise_date: The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025. Read SEC document |
| December 08, 2020 Filed May 4, 2021 20:30 UTC | Werewolf Therapeutics, Inc. HOWL · Entity 7244 | GrantStock Option (right to buy) · Derivative | 140,208 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0000899243-21-018114 · doc4.xml · derivative · entry 2 Isaacs Randi · CIK 0001857797 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,208 Underlying: Common Stock · 140,208 shares Expires 2030-12-07 F2 · derivative.exercise_date: The option was granted on December 8, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024. Read SEC document |
| November 09, 2020 Filed May 4, 2021 20:30 UTC | Werewolf Therapeutics, Inc. HOWL · Entity 7244 | GrantStock Option (right to buy) · Derivative | 176,966 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0000899243-21-018114 · doc4.xml · derivative · entry 1 Isaacs Randi · CIK 0001857797 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,966 Underlying: Common Stock · 176,966 shares Expires 2030-11-08 F1 · derivative.exercise_date: The option was granted on November 9, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through November 9, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.